All News

Researchers disagree on whether or not to monitor ovarian cancer survivors with frequent CA-125 tests. But this patient would rather have more information than less.

The mouth is also part of the body, and yet, it is only in the past few years that oncologists have begun recommending patients see a dentist before they begin treatment to be sure the teeth and gums are in good shape.

A new blood test may offer a less invasive alternative to tissue testing when identifying patients with non-small cell lung cancer (NSCLC) who could benefit from certain immunotherapies.

An expert discusses tips on how patients with cancer can manage their "scanxiety."

A 16-member team, including five patients with multiple myeloma, hiked through Iceland to raise money for disease research in hopes of finding a cure.

Living a post-cancer lifestyle means including your medical history on a health declaration form and learning to deal with the consequences.

Substitute thinking "life management" instead of "time management."

Dating after cancer can be scary, but dating with cancer can be down right daunting.

Nicholas J. Vogelzang, M.D., FASCO, FACP, has seen cancer through a variety of lenses – from oncologist to patient as well as caregiver – giving him a different perspective than most.

The Food and Drug Administration (FDA) approved the use of Lumoxiti (moxetumomab pasudotox-tdfk) for patients with relapsed or refractory hairy cell leukemia (HCL) who previously had at least two prior systemic therapies, including treatment with a purine nucleoside analog.

As a testicular cancer survivor, self-care through exercise is very important to me.

A study published in Blood demonstrated the significant disparities found between insurance status and survival outcomes in patients of all ages with follicular lymphoma.

The words celebrities use carry an enormous amount of weight.

The Food and Drug Administration (FDA) granted priority review to Keytruda (pembrolizumab) monotherapy for the first-line treatment of patients with locally advanced or metastatic nonsquamous or squamous non-small cell lung cancer (NSCLC) whose tumors express PD-L1 without EGFR or ALK genomic tumor aberrations.

A guy with breast cancer sees surviving in a new light.

Two-time cancer survivor encourages fellow survivors to develop resilience to cope with cancer.

Previously, there were concerns that older patients would not be able to handle the toxicities of the procedure, or that their stem cells, which are older, would not work as well. But that proved to not be the case.

The "cancer card" is one of the only upsides to being diagnosed with cancer... but when does it go too far?

A few thoughts and simple methods for finding a way to get back to the center of a life that includes all the emotions

A small study showed that, despite national guideline recommendation, conversations between doctors and patients about the benefits and harms of lung cancer screening in those who are at high risk are not happening the way they should be.

My hope is that more parents and caregivers find the benefits that yoga can offer for children with cancer.

CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, will launch its first television commercial featuring curetoday.com during the Stand Up To Cancer (SU2C) telecast tonight.

I felt like cancer had forced me to do other "uncomfortable" things instead of the bucket list I had chosen.

After success in the non-small cell lung cancer space, immunotherapy is finally making waves in the treatment of small cell lung cancer.

This infographic explains some of the basics on mantle cell lymphoma, a type of non-Hodgkin lymphoma.

By treating the patient as a whole, we ensure the common gaps in care do not get overlooked and the burden of cancer is reduced.

The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.

Have you ever wondered "why me" when diagnosed with cancer?